Epidemiological effectiveness of domestic influenza vaccines in cases with vaccination against a new coronavirus infection in 2022–2023

Author:

Lioznov Dmitry A.ORCID,Kuzin Aleksandr A.ORCID,Zobov Andrey Е.ORCID,Glushakov Ruslan I.ORCID,Erofeeva Mariana K.ORCID,Stukova Marina А.ORCID,Buzitskaya Zhanna V.ORCID,Golubtsov Oleg Y.ORCID

Abstract

The study presents the results of an epidemiological prospective field cohort study on a comparative assessment of the epidemiological effectiveness of domestic inactivated influenza vaccines and vaccines against new coronavirus infection during immunization of adults aged 18 years. Statistically significant differences were found in the incidence of influenza, acute upper respiratory infections, and new coronavirus infection between the vaccinated and unvaccinated groups. The etiologies of cases of acute upper respiratory infections registered in the study participants during the epidemic season of influenza in 2022–2023 were verified. The clinical symptoms of influenza in the vaccinated group were significantly less severe than those in the unvaccinated group. No significant differences were found in the clinical picture of acute upper respiratory infections between the compared groups. Influenza immunoprophylaxis is an urgent problem, which consists of the ability of viruses to change their antigenic structure and avoid immunity, remaining in constant circulation. Thus, the antigenic composition of influenza vaccines must be systematically updated to ensure the formation of effective population immunity. More studies on the etiological spectrum of respiratory pathogens and assessment of the epidemiological effectiveness of vaccination against vaccine-controlled infections in the analyzed groups are needed. Therefore, to assess immunological protection, including the assessment of the epidemiological effectiveness of seasonal vaccines used against influenza and new coronavirus infection, the priority age group includes individuals aged 18–25 years (especially those belonging to organized collectives) and adults with an unfavorable premorbid background. The use of domestic vaccines against influenza and the new coronavirus infection for specific immunoprophylaxis is generally recognized as the most effective sanitary and anti-epidemic (preventive) measure in the morbidity management of several infectious diseases.

Publisher

ECO-Vector LLC

Subject

General Medicine

Reference17 articles.

1. Global Influenza Program. Geneva: World Health Organization (WHO). 2010. P. 2–6.

2. Belov AB, Ogarkov PI. Current issues of epidemiology and immunization respiratory infection in the population and the military. Epidemiology and Vaccinal Prevention. 2012;1(62):4–11. (In Russ.).

3. Akimkin VG, Salmina TA, Shevtsov VA, Kalabukhova LYu. Assessment of the sanitary and epidemiological situation on the incidence of influenza A(H1N1)sw-09 in organized collectives of the Moscow region. Infection Diseases. 2010;8(1):12. (In Russ.)

4. Belov AB, Ogarkov PI. Epidemiology and prophylaxis of influenza and other acute respiratory infections occurred in the 32 military collectives. Military Medical Journal. 2005;326(3):31–38. (In Russ.)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3